Rein Therapeutics Inc. (RNTX)
NASDAQ · Healthcare
Rein Therapeutics Inc. Shareholder Equity 2015–2025
Rein Therapeutics Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Rein Therapeutics Inc. shareholder equity as of December 31, 2025: 16.9M, a 68.90% decrease year-over-year.
- Rein Therapeutics Inc. shareholder equity for 2025 were 16.9M, a 68.90% decrease from 2024.
- Rein Therapeutics Inc. shareholder equity for 2024 were 54.4M, a 44.67% decrease from 2023.
- Rein Therapeutics Inc. shareholder equity for 2023 were 98.3M, a 427.83% increase from 2022.
- Rein Therapeutics Inc. shareholder equity for 2022 were 18.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Rein Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $17 |
| 2024 | $54 |
| 2023 | $98 |
| 2022 | $19 |
| 2021 | $44 |
| 2020 | $12 |
| 2019 | $16 |
| 2018 | $20 |
| 2017 | $48 |
| 2016 | $-112 |
Rein Therapeutics Inc. Shareholder Equity — FAQ
Rein Therapeutics Inc. (RNTX) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RNTX's shareholder equity history?
The chart and table above show Rein Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.